{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:04:32Z","timestamp":1790553872054,"version":"4.1.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T00:00:00Z","timestamp":1622764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T00:00:00Z","timestamp":1622764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Depression constitutes a leading cause of disability worldwide. Despite extensive research on its interaction with psychobiological factors, associated pathways are far from being elucidated. Metabolomics, assessing the final products of complex biochemical reactions, has emerged as a valuable tool for exploring molecular pathways. We conducted a metabolome-wide association analysis to investigate the link between the serum metabolome and depressed mood (DM) in 1411 participants of the KORA (Cooperative Health Research in the Augsburg Region) F4 study (discovery cohort). Serum metabolomics data comprised 353 unique metabolites measured by Metabolon. We identified 72 (5.1%) KORA participants with DM. Linear regression tests were conducted modeling each metabolite value by DM status, adjusted for age, sex, body-mass index, antihypertensive, cardiovascular, antidiabetic, and thyroid gland hormone drugs, corticoids and antidepressants. Sensitivity analyses were performed in subcohorts stratified for sex, suicidal ideation, and use of antidepressants. We replicated our results in an independent sample of 968 participants of the SHIP-Trend (Study of Health in Pomerania) study including 52 (5.4%) individuals with DM (replication cohort). We found significantly lower laurylcarnitine levels in KORA F4 participants with DM after multiple testing correction according to Benjamini\/Hochberg. This finding was replicated in the independent SHIP-Trend study. Laurylcarnitine remained significantly associated (<jats:italic>p<\/jats:italic>value\u2009&lt;\u20090.05) with depression in samples stratified for sex, suicidal ideation, and antidepressant medication. Decreased blood laurylcarnitine levels in depressed individuals may point to impaired fatty acid oxidation and\/or mitochondrial function in depressive disorders, possibly representing a novel therapeutic target.<\/jats:p>","DOI":"10.1038\/s41380-021-01176-0","type":"journal-article","created":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T11:06:39Z","timestamp":1622804799000},"page":"7372-7383","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["A metabolome-wide association study in the general population reveals decreased levels of serum laurylcarnitine in people with depression"],"prefix":"10.1038","volume":"26","author":[{"given":"Helena U.","family":"Zacharias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Hertel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamimatunnisa","family":"Johar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maik","family":"Pietzner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karoline","family":"Lukaschek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seryan","family":"Atasoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Kunze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"V\u00f6lzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6678-7964","authenticated-orcid":false,"given":"Matthias","family":"Nauck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nele","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabi","family":"Kastenm\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans J.","family":"Grabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Gieger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Krumsiek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0221-311X","authenticated-orcid":false,"given":"Karl-Heinz","family":"Ladwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,4]]},"reference":[{"key":"1176_CR1","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1590\/1516-4446-2020-0650","volume":"42","author":"L Guti\u00e9rrez-Rojas","year":"2020","unstructured":"Guti\u00e9rrez-Rojas L, Porras-Segovia A, Dunne H, Andrade-Gonz\u00e1lez N, Cervilla JA. Prevalence and correlates of major depressive disorder: a systematic review. Braz J Psychiatry. 2020;42:657\u201372.","journal-title":"Braz J Psychiatry"},{"key":"1176_CR2","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1177\/0004867413513342","volume":"48","author":"GS Malhi","year":"2014","unstructured":"Malhi GS, Coulston CM, Fritz K, Lampe L, Bargh DM, Ablett M, et al. Unlocking the diagnosis of depression in primary care: Which key symptoms are GPs using to determine diagnosis and severity. Aust N Z J Psychiatry. 2014;48:542\u20137.","journal-title":"Aust N Z J Psychiatry"},{"key":"1176_CR3","doi-asserted-by":"publisher","first-page":"e1001547","DOI":"10.1371\/journal.pmed.1001547","volume":"10","author":"AJ Ferrari","year":"2013","unstructured":"Ferrari AJ, Charlson FJ, Norman RE, Patten SB, Freedman G, Murray CJL, et al. Burden of depressive disorders by country, sex, age, and year: findings from the Global Burden of Disease Study 2010. PLoS Med. 2013;10:e1001547.","journal-title":"PLoS Med"},{"key":"1176_CR4","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1017\/S0033291715002743","volume":"46","author":"M Li","year":"2016","unstructured":"Li M, D\u2019Arcy C, Meng X. Maltreatment in childhood substantially increases the risk of adult depression and anxiety in prospective cohort studies: systematic review, meta-analysis, and proportional attributable fractions. Psychol Med. 2016;46:717\u201330.","journal-title":"Psychol Med"},{"key":"1176_CR5","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.psyneuen.2010.04.001","volume":"35","author":"U Knorr","year":"2010","unstructured":"Knorr U, Vinberg M, Kessing LV, Wetterslev J. Salivary cortisol in depressed patients versus control persons: a systematic review and meta-analysis. Psychoneuroendocrinology. 2010;35:1275\u201386.","journal-title":"Psychoneuroendocrinology"},{"key":"1176_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/neu.2016.69","volume":"30","author":"BE Leonard","year":"2018","unstructured":"Leonard BE. Inflammation and depression: a causal or coincidental link to the pathophysiology? Acta Neuropsychiatr. 2018;30:1\u201316.","journal-title":"Acta Neuropsychiatr"},{"key":"1176_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-016-2953-2","volume":"17","author":"Y Liu","year":"2016","unstructured":"Liu Y, Yieh L, Yang T, Drinkenburg W, Peeters P, Steckler T, et al. Metabolomic biosignature differentiates melancholic depressive patients from healthy controls. BMC Genom. 2016;17:669.","journal-title":"BMC Genom"},{"key":"1176_CR8","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/ajmg.b.32680","volume":"180","author":"K MacDonald","year":"2019","unstructured":"MacDonald K, Krishnan A, Cervenka E, Hu G, Guadagno E, Trakadis Y. Biomarkers for major depressive and bipolar disorders using metabolomics: a systematic review. Am J Med Genet Part B Neuropsychiatr Genet. 2019;180:122\u201337.","journal-title":"Am J Med Genet Part B Neuropsychiatr Genet"},{"key":"1176_CR9","doi-asserted-by":"crossref","unstructured":"Gadad BS, Jha MK, Czysz A, Furman JL, Mayes TL, Emslie MP, et al. Peripheral biomarkers of major depression and antidepressant treatment response: Current knowledge and future outlooks. J Affect Disord. 2018;233:3\u201314. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0165032717306717.","DOI":"10.1016\/j.jad.2017.07.001"},{"key":"1176_CR10","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.nbd.2009.02.019","volume":"35","author":"MP Quinones","year":"2009","unstructured":"Quinones MP, Kaddurah-Daouk R. Metabolomics tools for identifying biomarkers for neuropsychiatric diseases. Neurobiol Dis. 2009;35:165\u201376.","journal-title":"Neurobiol Dis."},{"key":"1176_CR11","doi-asserted-by":"crossref","unstructured":"Czysz AH, South C, Gadad BS, Arning E, Soyombo A, Bottiglieri T, et al. Can targeted metabolomics predict depression recovery? Results from the CO-MED trial. Transl Psychiatry. 2019;9:11.","DOI":"10.1038\/s41398-018-0349-6"},{"key":"1176_CR12","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/npp.2008.174","volume":"34","author":"R Kaddurah-Daouk","year":"2009","unstructured":"Kaddurah-Daouk R, Krishnan KRR. Metabolomics: a global biochemical approach to the study of central nervous system diseases. Neuropsychopharmacology. 2009;34:173\u201386.","journal-title":"Neuropsychopharmacology."},{"key":"1176_CR13","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.pnpbp.2019.03.010","volume":"93","author":"M Pedrini","year":"2019","unstructured":"Pedrini M, Cao B, Nani JVS, Cerqueira RO, Mansur RB, Tasic L, et al. Advances and challenges in development of precision psychiatry through clinical metabolomics on mood and psychotic disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2019;93:182\u20138.","journal-title":"disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"key":"1176_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41398-018-0183-x","volume":"8","author":"JX Pan","year":"2018","unstructured":"Pan JX, Xia JJ, Deng FL, Liang WW, Wu J, Yin BM, et al. Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study. Transl Psychiatry. 2018;8:1\u201310.","journal-title":"Transl Psychiatry"},{"key":"1176_CR15","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1021\/acs.jproteome.5b00144","volume":"14","author":"X Liu","year":"2015","unstructured":"Liu X, Zheng P, Zhao X, Zhang Y, Hu C, Li J, et al. Discovery and validation of plasma biomarkers for major depressive disorder classification based on liquid chromatography-mass spectrometry. J Proteome Res. 2015;14:2322\u201330.","journal-title":"J Proteome Res"},{"key":"1176_CR16","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/QAI.0000000000000551","volume":"69","author":"E Cassol","year":"2015","unstructured":"Cassol E, Misra V, Morgello S, Kirk GD, Mehta SH, Gabuzda D. Altered monoamine and acylcarnitine metabolites in HIV-positive and HIV-negative subjects with depression. J Acquir Immune Defic Syndr. 2015;69:18\u201328.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"1176_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41398-020-01097-6","volume":"11","author":"S MahmoudianDehkordi","year":"2021","unstructured":"MahmoudianDehkordi S, Ahmed AT, Bhattacharyya S, Han X, Baillie RA, Arnold M, et al. Alterations in acylcarnitines, amines, and lipids inform about the mechanism of action of citalopram\/escitalopram in major depression. Translational psychiatry. 2021;11:1\u201314.","journal-title":"Translational psychiatry."},{"key":"1176_CR18","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jad.2019.11.122","volume":"264","author":"AT Ahmed","year":"2020","unstructured":"Ahmed AT, MahmoudianDehkordi S, Bhattacharyya S, Arnold M, Liu D, Neavin D, et al. Acylcarnitine metabolomic profiles inform clinically-defined major depressive phenotypes. J Affect Disord. 2020;264:90\u20137.","journal-title":"J Affect Disord"},{"key":"1176_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep00667","volume":"2","author":"R Kaddurah-Daouk","year":"2012","unstructured":"Kaddurah-Daouk R, Yuan P, Boyle SH, Matson W, Wang Z, Zeng ZB, et al. Cerebrospinal fluid metabolome in mood disorders-remission state has a unique metabolic profile. Sci Rep. 2012;2:1\u201310.","journal-title":"Sci Rep"},{"key":"1176_CR20","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/gps.1690","volume":"22","author":"LA Paige","year":"2007","unstructured":"Paige LA, Mitchell MW, Krishnan KRR, Kaddurah-Daouk R, Steffens DC. A preliminary metabolomic analysis of older adults with and without depression. Int J Geriatr Psychiatry. 2007;22:418\u201323.","journal-title":"Int J Geriatr Psychiatry"},{"key":"1176_CR21","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1177\/0891988709358592","volume":"23","author":"DC Steffens","year":"2010","unstructured":"Steffens DC, Jiang W, Krishnan KRR, Karoly ED, Mitchell MW, O\u2019Connor CM, et al. Metabolomic differences in heart failure patients with and without major depression. J Geriatr Psychiatry Neurol. 2010;23:138\u201346.","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"1176_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41398-019-0507-5","volume":"9","author":"S Bhattacharyya","year":"2019","unstructured":"Bhattacharyya S, Ahmed AT, Arnold M, Liu D, Luo C, Zhu H, et al. Metabolomic signature of exposure and response to citalopram\/escitalopram in depressed outpatients. Transl Psychiatry. 2019;9:1\u201314.","journal-title":"Transl Psychiatry"},{"key":"1176_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0165267","volume":"11","author":"D Setoyama","year":"2016","unstructured":"Setoyama D, Kato TA, Hashimoto R, Kunugi H, Hattori K, Hayakawa K, et al. Plasma metabolites predict severity of depression and suicidal ideation in psychiatric patients-a multicenter pilot analysis. PLoS ONE. 2016;11:1\u201316.","journal-title":"PLoS ONE"},{"key":"1176_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0208238","volume":"13","author":"A Baranyi","year":"2018","unstructured":"Baranyi A, Meinitzer A, Rothenh\u00e4usler HB, Amouzadeh-Ghadikolai O, Lewinski DV, Breitenecker RJ, et al. Metabolomics approach in the investigation of depression biomarkers in pharmacologically induced immune-related depression. PLoS ONE. 2018;13:1\u201316.","journal-title":"PLoS ONE"},{"key":"1176_CR25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1055\/s-2005-858235","volume":"67","author":"R Holle","year":"2005","unstructured":"Holle R, Happich M, L\u00f6wel H, Wichmann HE. KORA\u2014a research platform for population based health research. Das Gesundheitswesen. 2005;67:19\u201325.","journal-title":"Das Gesundheitswesen"},{"key":"1176_CR26","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/ng.507","volume":"42","author":"T Illig","year":"2010","unstructured":"Illig T, Gieger C, Zhai G, R\u00f6misch-Margl W, Wang-Sattler R, Prehn C, et al. A genome-wide perspective of genetic variation in human metabolism. Nat Genet. 2010;42:137\u201341.","journal-title":"Nat Genet"},{"key":"1176_CR27","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/nature10354","volume":"477","author":"K Suhre","year":"2011","unstructured":"Suhre K, Shin SY, Petersen AK, Mohney RP, Meredith D, W\u00e4gele B, et al. Human metabolic individuality in biomedical and pharmaceutical research. Nature. 2011;477:54\u201362.","journal-title":"Nature."},{"key":"1176_CR28","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1093\/ije\/dyp394","volume":"40","author":"H V\u00f6lzke","year":"2011","unstructured":"V\u00f6lzke H, Alte D, Schmidt CO, Radke D, Lorbeer R, Friedrich N, et al. Cohort profile: the study of health in Pomerania. Int J Epidemiol. 2011;40:294\u2013307.","journal-title":"Int J Epidemiol"},{"key":"1176_CR29","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1001\/jama.282.18.1737","volume":"282","author":"RL Spitzer","year":"1999","unstructured":"Spitzer RL, Kroenke K, Williams JBW. Validation and utility of a self-report version of PRIME-MD: the PHQ Primary Care Study. J Am Med Assoc. 1999;282:1737\u201344.","journal-title":"J Am Med Assoc"},{"key":"1176_CR30","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0165-0327(03)00198-8","volume":"81","author":"B L\u00f6we","year":"2004","unstructured":"L\u00f6we B, Kroenke K, Herzog W, Gr\u00e4fe K. Measuring depression outcome with a brief self-report instrument: sensitivity to change of the Patient Health Questionnaire (PHQ-9). J Affect Disord. 2004;81:61\u20136.","journal-title":"J Affect Disord"},{"key":"1176_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-015-0282-y","volume":"13","author":"S Wahl","year":"2015","unstructured":"Wahl S, Vogt S, St\u00fcckler F, Krumsiek J, Bartel J, Kacprowski T, et al. Multi-omic signature of body weight change: Results from a population-based cohort study. BMC Med. 2015;13:1\u201317.","journal-title":"BMC Med"},{"key":"1176_CR32","doi-asserted-by":"publisher","first-page":"6656","DOI":"10.1021\/ac901536h","volume":"81","author":"AM Evans","year":"2009","unstructured":"Evans AM, DeHaven CD, Barrett T, Mitchell M, Milgram E. Integrated, nontargeted ultrahigh performance liquid chromatography\/ electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Anal Chem. 2009;81:6656\u201367.","journal-title":"Anal Chem"},{"key":"1176_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-018-0765-1","volume":"17","author":"A Masuch","year":"2018","unstructured":"Masuch A, Pietzner M, Bahls M, Budde K, Kastenm\u00fcller G, Zylla S, et al. Metabolomic profiling implicates adiponectin as mediator of a favorable lipoprotein profile associated with NT-proBNP. Cardiovasc Diabetol. 2018;17:1\u201312. https:\/\/doi.org\/10.1186\/s12933-018-0765-1.","journal-title":"Cardiovasc Diabetol"},{"key":"1176_CR34","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B. 1995;57:289\u2013300.","journal-title":"J R Stat Soc Ser B."},{"key":"1176_CR35","first-page":"275","volume":"55","author":"RR Team","year":"2013","unstructured":"Team RR. Development Core Team. R A Lang Environ. Stat Comput. 2013;55:275\u201386.","journal-title":"Stat Comput"},{"key":"1176_CR36","doi-asserted-by":"publisher","first-page":"D608","DOI":"10.1093\/nar\/gkx1089","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart DS, Feunang YD, Marcu A, Guo AC, Liang K, V\u00e1zquez-Fresno R, et al. HMDB 4.0: the human metabolome database for 2018. Nucleic Acids Res. 2018;46:D608\u201317.","journal-title":"Nucleic Acids Res"},{"key":"1176_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0221342","volume":"14","author":"D Meierhofer","year":"2019","unstructured":"Meierhofer D. Acylcarnitine profiling by low-resolution LC-MS. PLoS ONE. 2019;14:1\u201311.","journal-title":"PLoS ONE"},{"key":"1176_CR38","doi-asserted-by":"publisher","first-page":"3414","DOI":"10.1002\/pmic.200500069","volume":"6","author":"CL Beasley","year":"2006","unstructured":"Beasley CL, Pennington K, Behan A, Wait R, Dunn MJ, Cotter D. Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: Evidence for disease-associated changes. Proteomics. 2006;6:3414\u201325.","journal-title":"Proteomics."},{"key":"1176_CR39","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0165-0327(02)00067-8","volume":"76","author":"A Gardner","year":"2003","unstructured":"Gardner A, Johansson A, Wibom R, Nennesmo I, Von D\u00f6beln U, Hagenfeldt L, et al. Alterations of mitochondrial function and correlations with personality traits in selected major depressive disorder patients. J Affect Disord. 2003;76:55\u201368.","journal-title":"J Affect Disord"},{"key":"1176_CR40","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.mito.2013.05.005","volume":"13","author":"J Hroudov\u00e1","year":"2013","unstructured":"Hroudov\u00e1 J, Fi\u0161ar Z, Kitzlerov\u00e1 E, Zv\u011b\u0159ov\u00e1 M, Raboch J. Mitochondrial respiration in blood platelets of depressive patients. Mitochondrion. 2013;13:795\u2013800.","journal-title":"Mitochondrion."},{"key":"1176_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2014.44","volume":"4","author":"A Karabatsiakis","year":"2014","unstructured":"Karabatsiakis A, B\u00f6ck C, Salinas-Manrique J, Kolassa S, Calzia E, Dietrich DE, et al. Mitochondrial respiration in peripheral blood mononuclear cells correlates with depressive subsymptoms and severity of major depression. Transl Psychiatry. 2014;4:e397.","journal-title":"Transl Psychiatry"},{"key":"1176_CR42","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s10863-014-9584-6","volume":"47","author":"NJ Klinedinst","year":"2015","unstructured":"Klinedinst NJ, Regenold WT. A mitochondrial bioenergetic basis of depression. J Bioenerg Biomembr. 2015;47:155\u201371.","journal-title":"J Bioenerg Biomembr"},{"key":"1176_CR43","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nrn3229","volume":"13","author":"H Manji","year":"2012","unstructured":"Manji H, Kato T, Di Prospero NA, Ness S, Beal MF, Krams M, et al. Impaired mitochondrial function in psychiatric disorders. Nat Rev Neurosci. 2012;13:293\u2013307.","journal-title":"Nat Rev Neurosci"},{"key":"1176_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2015.18","volume":"5","author":"A Flaquer","year":"2015","unstructured":"Flaquer A, Baumbach C, Ladwig KH, Kriebel J, Waldenberger M, Grallert H, et al. Mitochondrial genetic variants identified to be associated with posttraumatic stress disorder. Transl Psychiatry. 2015;5:e524.","journal-title":"Transl Psychiatry"},{"key":"1176_CR45","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0074-7742(04)59011-6","volume":"59","author":"D Ben-Shachar","year":"2004","unstructured":"Ben-Shachar D, Laifenfeld D. Mitochondria, synaptic plasticity, and schizophrenia. Int Rev Neurobiol. 2004;59:273\u201396.","journal-title":"Int Rev Neurobiol"},{"key":"1176_CR46","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1001\/archpsyc.61.3.300","volume":"61","author":"C Konradi","year":"2004","unstructured":"Konradi C, Eaton M, MacDonald ML, Walsh J, Benes FM, Heckers S. Molecular evidence for mitochondrial dysfunction in bipolar disorder. Arch Gen Psychiatry. 2004;61:300\u20138.","journal-title":"Arch Gen Psychiatry"},{"key":"1176_CR47","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.bbr.2005.06.012","volume":"165","author":"H Einat","year":"2005","unstructured":"Einat H, Yuan P, Manji HK. Increased anxiety-like behaviors and mitochondrial dysfunction in mice with targeted mutation of the Bcl-2 gene: Further support for the involvement of mitochondrial function in anxiety disorders. Behav Brain Res. 2005;165:172\u201380.","journal-title":"Behav Brain Res"},{"key":"1176_CR48","doi-asserted-by":"publisher","first-page":"3558","DOI":"10.1021\/acs.jproteome.7b00279","volume":"16","author":"K Kriisa","year":"2017","unstructured":"Kriisa K, Leppik L, Bal\u00f5t\u0161ev R, Ottas A, Soomets U, Koido K, et al. Profiling of acylcarnitines in first episode psychosis before and after antipsychotic treatment. J Proteome Res. 2017;16:3558\u201366.","journal-title":"J Proteome Res"},{"key":"1176_CR49","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1172\/JCI115856","volume":"90","author":"A Suomalainen","year":"1992","unstructured":"Suomalainen A, Majander A, Haltia M, Somer H, L\u00f6nnqvist J, Savontaus ML, et al. Multiple deletions of mitochondrial DNA in several tissues of a patient with severe retarded depression and familial progressive external ophthalmoplegia. J Clin Investig. 1992;90:61\u20136.","journal-title":"J Clin Investig"},{"key":"1176_CR50","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1002\/(SICI)1097-4598(199612)19:12<1561::AID-MUS5>3.0.CO;2-8","volume":"19","author":"A Melberg","year":"1996","unstructured":"Melberg A, Arnell H, Dahl N, St\u00e5lberg E, Raininko R, Oldfors A, et al. Anticipation of autosomal dominant progressive external ophthalmoplegia with hypogonadism. Muscle Nerve. 1996;19:1561\u20139.","journal-title":"Muscle Nerve"},{"key":"1176_CR51","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/S0006-3223(97)00280-1","volume":"42","author":"H Miyaoka","year":"1997","unstructured":"Miyaoka H, Suzuki Y, Taniyama M, Miyaoka Y, Shishikura K, Kamijima K, et al. Mental disorders in diabetic patients with mitochondrial transfer RNA(Leu (UUR)) mutation at position 3243. Biol Psychiatry. 1997;42:524\u20136.","journal-title":"Biol Psychiatry"},{"key":"1176_CR52","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/S0006-3223(97)00005-X","volume":"41","author":"H Onishi","year":"1997","unstructured":"Onishi H, Kawanishi C, Iwasawa T, Osaka H, Hanihara T, Inoue K, et al. Depressive disorder due to mitochondrial transfer RNA(Leu(UUR)) mutation. Biol Psychiatry. 1997;41:1137\u20139.","journal-title":"Biol Psychiatry"},{"key":"1176_CR53","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/ana.410420220","volume":"42","author":"FM Santorelli","year":"1997","unstructured":"Santorelli FM, Tanji K, Sano M, Shanske S, El-Shahawi M, Kranz-Eble P, et al. Maternally inherited encephalopathy associated with a single-base insertion in the mitochondrial tRNA(Trp) gene. Ann Neurol. 1997;42:256\u201360.","journal-title":"Ann Neurol"},{"key":"1176_CR54","doi-asserted-by":"publisher","first-page":"506","DOI":"10.4088\/JCP.11r07237","volume":"73","author":"RE Anglin","year":"2012","unstructured":"Anglin RE, Garside SL, Tarnopolsky MA, Mazurek MF, Rosebush PI. The psychiatric manifestations of mitochondrial disorders: a case and review of the literature. J Clin Psychiatry. 2012;73:506\u201312.","journal-title":"J Clin Psychiatry"},{"key":"1176_CR55","doi-asserted-by":"crossref","unstructured":"Fattal O, Link J, Quinn K, Cohen BH, Franco K. Psychiatric comorbidity in 36 adults with mitochondrial cytopathies. CNS Spectr. 2007;12:429\u201338. https:\/\/www.cambridge.org\/core\/article\/psychiatric-comorbidity-in-36-adults-with-mitochondrial-cytopathies\/65F57A79CA81A901FE4454ED2F75990A.","DOI":"10.1017\/S1092852900015303"},{"key":"1176_CR56","doi-asserted-by":"crossref","unstructured":"Lopresti AL. Mitochondrial dysfunction and oxidative stress: relevance to the pathophysiology and treatment of depression. Neurobiol Depress. 2019:159\u201368.","DOI":"10.1016\/B978-0-12-813333-0.00015-9"},{"key":"1176_CR57","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.neuint.2012.04.008","volume":"61","author":"OB Smeland","year":"2012","unstructured":"Smeland OB, Meisingset TW, Borges K, Sonnewald U. Chronic acetyl-l-carnitine alters brain energy metabolism and increases noradrenaline and serotonin content in healthy mice. Neurochem Int. 2012;61:100\u20137. https:\/\/doi.org\/10.1016\/j.neuint.2012.04.008.","journal-title":"Neurochem Int"},{"key":"1176_CR58","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jpsychires.2014.02.005","volume":"53","author":"SM Wang","year":"2014","unstructured":"Wang SM, Han C, Lee SJ, Patkar AA, Masand PS, Pae CU. A review of current evidence for acetyl-l-carnitine in the treatment of depression. J Psychiatr Res. 2014;53:30\u20137. https:\/\/doi.org\/10.1016\/j.jpsychires.2014.02.005.","journal-title":"J Psychiatr Res"},{"key":"1176_CR59","doi-asserted-by":"publisher","first-page":"4804 LP","DOI":"10.1073\/pnas.1216100110","volume":"110","author":"C Nasca","year":"2013","unstructured":"Nasca C, Xenos D, Barone Y, Caruso A, Scaccianoce S, Matrisciano F, et al. L-acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors. Proc Natl Acad Sci USA. 2013;110:4804 LP\u20139. http:\/\/www.pnas.org\/content\/110\/12\/4804.abstract.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1176_CR60","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.neuroscience.2014.11.025","volume":"285","author":"W Wang","year":"2015","unstructured":"Wang W, Lu Y, Xue Z, Li C, Wang C, Zhao X, et al. Rapid-acting antidepressant-like effects of acetyl-l-carnitine mediated by PI3K\/AKT\/BDNF\/VGF signaling pathway in mice. Neuroscience. 2015;285:281\u201391.","journal-title":"Neuroscience."},{"key":"1176_CR61","doi-asserted-by":"crossref","unstructured":"Nasca C, Bigio B, Lee FS, Young SP, Kautz MM, Albright A, et al. Acetyl-L-carnitine deficiency in patients with major depressive disorder. Proc Natl Acad Sci USA. 2018;115:8627 LP\u201332. http:\/\/www.pnas.org\/content\/115\/34\/8627.abstract.","DOI":"10.1073\/pnas.1801609115"},{"key":"1176_CR62","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1111\/j.1469-7610.2010.02245.x","volume":"51","author":"V Gabbay","year":"2010","unstructured":"Gabbay V, Klein RG, Katz Y, Mendoza S, Guttman LE, Alonso CM, et al. The possible role of the kynurenine pathway in adolescent depression with melancholic features. J Child Psychol Psychiatry. 2010;51:935\u201343.","journal-title":"J Child Psychol Psychiatry"},{"key":"1176_CR63","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.psychres.2015.03.031","volume":"227","author":"KAL Bradley","year":"2015","unstructured":"Bradley KAL, Case JAC, Khan O, Ricart T, Hanna A, Alonso CM, et al. The role of the kynurenine pathway in suicidality in adolescent major depressive disorder. Psychiatry Res. 2015;227:206\u201312.","journal-title":"Psychiatry Res"},{"key":"1176_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41398-017-0056-8","volume":"8","author":"D Liu","year":"2018","unstructured":"Liu D, Ray B, Neavin DR, Zhang J, Athreya AP, Biernacka JM, et al. Beta-defensin 1, aryl hydrocarbon receptor and plasma kynurenine in major depressive disorder: metabolomics-informed genomics. Transl Psychiatry. 2018;8:1\u201313.","journal-title":"Transl Psychiatry"},{"key":"1176_CR65","doi-asserted-by":"crossref","unstructured":"Bot M, Milaneschi Y, Al-Shehri T, Amin N, Garmaeva S, Onderwater GLJ, et al. Metabolomics profile in depression: a pooled analysis of 230 metabolic markers in 5283 cases with depression and 10,145 controls. Biol Psychiatry. 2020;87:409\u201318. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0006322319316282.","DOI":"10.1016\/j.biopsych.2019.08.016"},{"key":"1176_CR66","doi-asserted-by":"crossref","unstructured":"Penninx BWJH, Eikelenboom M, Giltay EJ, van Hemert AM, Riese H, Schoevers RA, et al. Cohort profile of the longitudinal Netherlands Study of Depression and Anxiety (NESDA) on etiology, course and consequences of depressive and anxiety disorders. J Affect Disord. 2021;287:69\u201377.","DOI":"10.1016\/j.jad.2021.03.026"},{"key":"1176_CR67","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jpsychires.2016.03.001","volume":"78","author":"MH Trivedi","year":"2016","unstructured":"Trivedi MH, McGrath PJ, Fava M, Parsey RV, Kurian BT, Phillips ML, et al. Establishing moderators and biosignatures of antidepressant response in clinical care (EMBARC): rationale and design. J Psychiatr Res. 2016;78:11\u201323.","journal-title":"J Psychiatr Res"},{"key":"1176_CR68","doi-asserted-by":"publisher","first-page":"e68283","DOI":"10.1371\/journal.pone.0068283","volume":"8","author":"H Zhu","year":"2013","unstructured":"Zhu H, Bogdanov MB, Boyle SH, Matson W, Sharma S, Matson S, et al. Pharmacometabolomics of response to sertraline and to placebo in major depressive disorder\u2014possible role for methoxyindole pathway. PLoS ONE. 2013;8:e68283. https:\/\/doi.org\/10.1371\/journal.pone.0068283.","journal-title":"PLoS ONE"},{"key":"1176_CR69","doi-asserted-by":"publisher","first-page":"e894","DOI":"10.1038\/tp.2016.145","volume":"6","author":"DM Rotroff","year":"2016","unstructured":"Rotroff DM, Corum DG, Motsinger-Reif A, Fiehn O, Bottrel N, Drevets WC, et al. Metabolomic signatures of drug response phenotypes for ketamine and esketamine in subjects with refractory major depressive disorder: new mechanistic insights for rapid acting antidepressants. Transl Psychiatry. 2016;6:e894.","journal-title":"Transl Psychiatry"},{"key":"1176_CR70","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1038\/tp.2011.22","volume":"1","author":"R Kaddurah-Daouk","year":"2011","unstructured":"Kaddurah-Daouk R, Boyle SH, Matson W, Sharma S, Matson S, Zhu H, et al. Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept. Transl Psychiatry. 2011;1:e26.","journal-title":"Transl Psychiatry"},{"key":"1176_CR71","doi-asserted-by":"publisher","first-page":"e13953.","DOI":"10.1371\/journal.pone.0013953","volume":"5","author":"K Suhre","year":"2010","unstructured":"Suhre K, Meisinger C, D\u00f6ring A, Altmaier E, Belcredi P, Gieger C, et al. Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting. PLoS ONE. 2010;5:e13953. https:\/\/doi.org\/10.1371\/journal.pone.0013953.","journal-title":"PLoS ONE"},{"key":"1176_CR72","doi-asserted-by":"publisher","first-page":"e0153672","DOI":"10.1371\/journal.pone.0153672","volume":"11","author":"I Yet,","year":"2016","unstructured":"Yet I, Menni C, Shin SY, Mangino M, Soranzo N, Adamski J, et al. Genetic influences on metabolite levels: a comparison across metabolomic platforms. PLoS ONE. 2016;11:e0153672.","journal-title":"PLoS ONE"},{"key":"1176_CR73","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.eurpsy.2017.02.479","volume":"43","author":"EEM Knowles","year":"2017","unstructured":"Knowles EEM, Huynh K, Meikle PJ, G\u00f6ring HHH, Olvera RL, Mathias SR, et al. The lipidome in major depressive disorder: shared genetic influence for ether-phosphatidylcholines, a plasma-based phenotype related to inflammation, and disease risk. Eur Psychiatry. 2017;43:44\u201350.","journal-title":"Eur Psychiatry"},{"key":"1176_CR74","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1038\/mp.2016.6","volume":"21","author":"M Gupta","year":"2016","unstructured":"Gupta M, Neavin D, Liu D, Biernacka J, Hall-Flavin D, Bobo WV, et al. TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics. Mol Psychiatry. 2016;21:1717\u201325.","journal-title":"Mol Psychiatry"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-021-01176-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-021-01176-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-021-01176-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T06:34:46Z","timestamp":1725172486000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-021-01176-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,4]]},"references-count":74,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1176"],"URL":"https:\/\/doi.org\/10.1038\/s41380-021-01176-0","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,4]]},"assertion":[{"value":"22 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"HJG has received travel grants and speakers honoraria from Fresenius Medical Care, Neuraxpharm, Servier, and Janssen Cilag as well as research funding from Fresenius Medical Care.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}